Angiography

HeartFlow Applauds Healthcare Stakeholders’ Push for Change in How Coronary Artery Disease is First Diagnosed

Retrieved on: 
Thursday, October 29, 2020
Biotechnology, Health, Technology, Cardiology, Software, Circulatory system, Cardiovascular system, Anatomy, Heart diseases, Aging-associated diseases, Acute pain, Coronary artery disease, Angina, Coronary arteries, Angiography, Heart, Coronary catheterization, the HeartFlow FFRct Analysis, HeartFlow, Inc.

The article was authored by prominent healthcare stakeholders representing physician societies, provider institutions and government and commercial health plans.

Key Points: 
  • The article was authored by prominent healthcare stakeholders representing physician societies, provider institutions and government and commercial health plans.
  • We welcome this CTA-first approach which has broad support within the healthcare ecosystem globally, said Campbell Rogers, M.D., FACC, Chief Medical Officer, HeartFlow.
  • HeartFlow, Inc. is a digital health company uniquely positioned at the intersection of advanced artificial intelligence and healthcare to transform how heart disease is diagnosed and treated.
  • Effect of the Presence and Type of Angina on Cardiovascular Events in Patients Without Known Coronary Artery Disease Referred for Elective Coronary Angiography.

Global Angiography Devices Industry

Retrieved on: 
Wednesday, October 21, 2020
Projectional radiography, Angiography

US Angiography Devices Market Share (in %) by Company: 2019 & 2025

Key Points: 
  • US Angiography Devices Market Share (in %) by Company: 2019 & 2025
    and Projections in US$ Million by Product: 2020 to 2027
    Retrospective Analysis in US$ Million by Technology: 2012-2019
    and Projections in US$ Million by Procedure: 2020 to 2027
    Forecasts in US$ Million by End-Use: 2020 to 2027
    Forecasts in US$ Million by Product: 2020 to 2027
    by Product in US$ Million: 2012-2019
    Table 75: Angiography Devices Market in Canada: Percentage
    Share Breakdown of Sales by Product for 2012, 2020, and 2027
    Table 77: Angiography Devices Market in Canada: Historic Review
    Forecasts in US$ Million by Procedure: 2020 to 2027
    by Procedure in US$ Million: 2012-2019
    Table 81: Angiography Devices Market in Canada: Percentage
    Share Breakdown of Sales by Procedure for 2012, 2020, and 2027
    Demand Analysis in US$ Million by End-Use: 2020 to 2027
    Table 83: Angiography Devices Market in Canada: Summarization
    Table 85: Japanese Market for Angiography Devices: Annual Sales
    Table 86: Angiography Devices Market in Japan: Historic Sales
    Devices Market in US$ Million by Technology: 2020-2027
    Table 91: Japanese Market for Angiography Devices: Annual Sales
    Table 92: Angiography Devices Market in Japan: Historic Sales
    Angiography Devices in US$ Million by End-Use: 2020 to 2027
    in US$ Million by Product: 2012-2019
    Table 99: Chinese Angiography Devices Market by Product:
    Percentage Breakdown of Sales for 2012, 2020, and 2027
    in China in US$ Million by Technology: 2020-2027
    Scenario in US$ Million by Technology: 2012-2019
    Table 102: Angiography Devices Market in China: Percentage
    Share Analysis by Technology for 2012, 2020, and 2027
    China in US$ Million by Procedure: 2012-2019
    Table 105: Chinese Angiography Devices Market by Procedure:
    Percentage Breakdown of Sales for 2012, 2020, and 2027
    in US$ Million by Region/Country: 2020-2027
    Table 110: Angiography Devices Market in Europe: A Historic
    Forecasts in US$ Million by Product: 2020-2027
    in US$ Million by Technology: 2012-2019
    Table 117: Angiography Devices Market in Europe: Percentage
    Breakdown of Sales by Technology for 2012, 2020, and 2027
    Forecasts in US$ Million by Procedure: 2020-2027
    Opportunity in US$ Million by End-Use: 2020-2027
    Table 122: Angiography Devices Market in Europe: Summarization
    Table 124: Angiography Devices Market in France by Product:
    in US$ Million by Product: 2012-2019
    Projections in US$ Million by Technology: 2020-2027
    in US$ Million by Technology: 2012-2019
    Table 130: Angiography Devices Market in France by Procedure:
    in US$ Million by Procedure: 2012-2019
    France in US$ Million by End-Use: 2020-2027
    Table 135: French Angiography Devices Market Share Analysis:
    A 17-Year Perspective by End-Use for 2012, 2020, and 2027
    Table 136: Angiography Devices Market in Germany: Recent Past,
    in US$ Million by Product: 2012-2019
    in US$ Million by Technology: 2020-2027
    Table 140: Angiography Devices Market in Germany: A Historic
    Table 142: Angiography Devices Market in Germany: Recent Past,
    in US$ Million by Procedure: 2012-2019
    Table 145: Angiography Devices Market in Germany: Annual Sales
    Italy in US$ Million by Product: 2012-2019
    Table 150: Italian Angiography Devices Market by Product:
    Percentage Breakdown of Sales for 2012, 2020, and 2027
    in Italy in US$ Million by Technology: 2020-2027
    Scenario in US$ Million by Technology: 2012-2019
    Table 153: Angiography Devices Market in Italy: Percentage
    Share Analysis by Technology for 2012, 2020, and 2027
    Italy in US$ Million by Procedure: 2012-2019
    Table 156: Italian Angiography Devices Market by Procedure:
    Percentage Breakdown of Sales for 2012, 2020, and 2027
    Table 160: United Kingdom Market for Angiography Devices:
    Table 161: Angiography Devices Market in the United Kingdom:
    Angiography Devices Market in US$ Million by Technology:
    Table 166: United Kingdom Market for Angiography Devices:
    Table 167: Angiography Devices Market in the United Kingdom:
    Angiography Devices in US$ Million by End-Use: 2020 to 2027
    Forecasts in US$ Million by Product: 2020 to 2027
    by Product in US$ Million: 2012-2019
    Table 174: Angiography Devices Market in Spain: Percentage
    Share Breakdown of Sales by Product for 2012, 2020, and 2027
    Table 176: Angiography Devices Market in Spain: Historic Review
    Forecasts in US$ Million by Procedure: 2020 to 2027
    by Procedure in US$ Million: 2012-2019
    Table 180: Angiography Devices Market in Spain: Percentage
    Share Breakdown of Sales by Procedure for 2012, 2020, and 2027
    Demand Analysis in US$ Million by End-Use: 2020 to 2027
    Table 182: Angiography Devices Market in Spain: Summarization
    Projections in US$ Million by Product: 2020 to 2027
    Table 185: Angiography Devices Market in Russia by Product:
    Analysis in US$ Million by Technology: 2012-2019
    Projections in US$ Million by Procedure: 2020 to 2027
    Table 191: Angiography Devices Market in Russia by Procedure:
    in US$ Million by End-Use: 2020 to 2027
    and Forecasts in US$ Million by Product: 2020-2027
    in US$ Million by Technology: 2020-2027
    Review in US$ Million by Technology: 2012-2019
    Table 201: Angiography Devices Market in Rest of Europe:
    Percentage Breakdown of Sales by Technology for 2012, 2020, and
    and Forecasts in US$ Million by Procedure: 2020-2027
    Market Opportunity in US$ Million by End-Use: 2020-2027
    Table 206: Angiography Devices Market in Rest of Europe:
    and Forecasts in US$ Million by Region/Country: 2020-2027
    Table 209: Angiography Devices Market in Asia-Pacific: Historic
    Scenario in US$ Million by Product: 2012-2019
    and Projections in US$ Million by Technology: 2020-2027
    Analysis in US$ Million by Technology: 2012-2019
    Analysis in US$ Million by Technology: 2012 VS 2020 VS 2027
    Scenario in US$ Million by Procedure: 2012-2019
    Asia-Pacific in US$ Million by End-Use: 2020-2027
    Review in US$ Million by End-Use: 2012-2019
    Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and
    Table 223: Angiography Devices Market in Australia: Recent
    Analysis in US$ Million by Product: 2012-2019
    Forecasts in US$ Million by Technology: 2020-2027
    Table 227: Angiography Devices Market in Australia: A Historic
    Table 229: Angiography Devices Market in Australia: Recent
    Analysis in US$ Million by Procedure: 2012-2019
    Table 232: Angiography Devices Market in Australia: Annual
    in US$ Million by End-Use: 2012-2019
    Forecasts in US$ Million by Product: 2020 to 2027
    Table 237: Angiography Devices Market in India: Percentage
    Share Breakdown of Sales by Product for 2012, 2020, and 2027
    Table 239: Angiography Devices Market in India: Historic Review
    Forecasts in US$ Million by Procedure: 2020 to 2027
    Table 243: Angiography Devices Market in India: Percentage
    Share Breakdown of Sales by Procedure for 2012, 2020, and 2027
    Demand Analysis in US$ Million by End-Use: 2020 to 2027
    Table 245: Angiography Devices Market in India: Summarization
    Table 247: Angiography Devices Market in South Korea: Recent
    Analysis in US$ Million by Product: 2012-2019
    Table 250: Angiography Devices Market in South Korea: Recent
    Analysis in US$ Million by Technology: 2012-2019
    Table 253: Angiography Devices Market in South Korea: Recent
    Analysis in US$ Million by Procedure: 2012-2019
    Table 256: Angiography Devices Market in South Korea: Recent
    Analysis in US$ Million by End-Use: 2012-2019
    Table 259: Rest of Asia-Pacific Market for Angiography Devices:
    Table 260: Angiography Devices Market in Rest of Asia-Pacific:
    Angiography Devices Market in US$ Million by Technology:
    in US$ Million by Technology: 2012-2019
    Percentage Share Distribution by Technology: 2012 VS 2020 VS
    Table 265: Rest of Asia-Pacific Market for Angiography Devices:
    Table 266: Angiography Devices Market in Rest of Asia-Pacific:
    ReportLinker is an award-winning market research solution.
  • Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

New Data Highlight a Significant Increase in Cardiovascular Treatment Efficiency when the HeartFlow Analysis is Incorporated into the Diagnostic Pathway

Retrieved on: 
Friday, October 16, 2020
General Health, Health, Technology, Cardiology, Software, Medical tests, CT scan, Multidimensional signal processing, Angiography, the HeartFlow FFRct Analysis, HeartFlow, Inc.

Late-breaking results presented today confirm that incorporating the HeartFlow FFRct Analysis into a coronary computed tomography angiogram (CTA)-led diagnostic pathway significantly increases overall cardiovascular treatment efficiency.

Key Points: 
  • Late-breaking results presented today confirm that incorporating the HeartFlow FFRct Analysis into a coronary computed tomography angiogram (CTA)-led diagnostic pathway significantly increases overall cardiovascular treatment efficiency.
  • In 2017, NICE recommended the HeartFlow Analysis as the most cost-effective option following a coronary CTA when additional information is needed by the clinician.
  • The HeartFlow Analysis is a non-invasive, cardiac test for stable symptomatic patients with CAD, the leading cause of death worldwide.
  • Data demonstrating the safety, efficacy and cost-effectiveness of the HeartFlow Analysis have been published in more than 400 peer-reviewed publications, including long-term data out to five years.

Shockwave IVL Meets Safety and Effectiveness Endpoints in U.S. Coronary Pivotal IDE Study

Retrieved on: 
Thursday, October 15, 2020
Interventional radiology, Medicine, Medical specialties, Clinical medicine, Stent, Angiography, Atherectomy

Disrupt CAD III is a prospective, multicenter, single-arm, global IDE study investigating the Shockwave Coronary IVL System in de novo, calcified, stenotic, coronary arteries prior to stenting.

Key Points: 
  • Disrupt CAD III is a prospective, multicenter, single-arm, global IDE study investigating the Shockwave Coronary IVL System in de novo, calcified, stenotic, coronary arteries prior to stenting.
  • Disrupt CAD III was based on a predicate study the single-arm ORBIT II IDE study of orbital atherectomy to develop performance goals that would allow FDA to evaluate the safety and effectiveness of IVL in a single arm study.
  • Coronary IVL prior to stent implantation was well tolerated with a low rate of major peri-procedural clinical and angiographic complications.
  • CAD III demonstrated the effectiveness of coronary IVL in treating calcium with large lumen gains that facilitated stent delivery.

AngioDynamics Announces Commercial Launch of Auryon Atherectomy System in United States

Retrieved on: 
Monday, September 21, 2020
Health, Surgery, Cardiology, Medical devices, Medical specialties, Clinical medicine, Medicine, Interventional radiology, Atherectomy, Vascular surgery, Angiography, Laser

The Auryon Atherectomy System is the first laser atherectomy system to efficiently treat lesions of any type, length, or location (above and below the knee), with minimal impact on vessel walls1.

Key Points: 
  • The Auryon Atherectomy System is the first laser atherectomy system to efficiently treat lesions of any type, length, or location (above and below the knee), with minimal impact on vessel walls1.
  • AngioDynamics is proud to make the Auryon Atherectomy System, and its solid-state laser technology, available to providers and patients nationwide.
  • The launch of the Auryon Atherectomy System is supported by the launch of Auryon-PAD.com .
  • On the site, visitors can learn about the science behind the Auryon Atherectomy System, read recent case studies, and access videos to explore the technology behind the Auryon Atherectomy System.

AngioDynamics to Report Fiscal 2021 First Quarter Financial Results on September 29, 2020

Retrieved on: 
Thursday, September 17, 2020
Oncology, Medical devices, Health, Surgery, Cardiology, Biotechnology, Medicine, Clinical medicine, Medical specialties, Medical equipment, Oncology, Catheters, Port, Angiography

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will report financial results for the first quarter of fiscal year 2021 before the market open on Tuesday, September 29, 2020.

Key Points: 
  • AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will report financial results for the first quarter of fiscal year 2021 before the market open on Tuesday, September 29, 2020.
  • To participate in the conference call, dial 1-877-407-0784 (domestic) or +1-201-689-8560 (international) and refer to the passcode 13710506.
  • This conference call will also be webcast and can be accessed from the Investors section of the AngioDynamics website at www.angiodynamics.com .
  • AngioDynamics diverse product lines include market-leading ablation systems, vascular access products, angiographic products and accessories, drainage products, thrombolytic products and venous products.

Peripheral Vascular Devices Market by Type, Plaque Modification and Region - Global Forecast to 2025 - ResearchAndMarkets.com

Retrieved on: 
Thursday, September 10, 2020
Professional services, Consulting, Interventional radiology, Medicine, Clinical medicine, Medical specialties, Angioplasty, Atherectomy, Intravascular ultrasound, Angiography, Stent, Donald S. Baim

The "Peripheral Vascular Devices Market by Type (Angioplasty Balloon, Stent, Catheters (Angiography, IVUS), Plaque Modification (Atherectomy, Thrombectomy), Hemodynamic Flow Alteration, IVC Filters, Guidewires), and Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Peripheral Vascular Devices Market by Type (Angioplasty Balloon, Stent, Catheters (Angiography, IVUS), Plaque Modification (Atherectomy, Thrombectomy), Hemodynamic Flow Alteration, IVC Filters, Guidewires), and Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
  • The global peripheral vascular devices market is projected to reach USD 12,670.8 million by 2025 from an estimated USD 9,232.5 million in 2020, at a CAGR of 6.5%.
  • Embolic protection devices accounted for the largest share of the peripheral vascular devices market in 2019.
  • Based on type, the hemodynamic flow alteration devices market is segmented into embolic protection devices and chronic total occlusion devices.

Global Coronary Angiography Devices Market (2019 to 2024) - Featuring Boston Scientific, Medtronic & Teleflex Among Others - ResearchAndMarkets.com

Retrieved on: 
Thursday, September 3, 2020
Medical devices, Health, Coronary catheterization, Angiography, Medical device

The "Global Coronary Angiography Devices Market" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Coronary Angiography Devices Market" report has been added to ResearchAndMarkets.com's offering.
  • This report was developed using extensive primary and secondary research by the publisher's analysts.
  • Data from proprietary databases, proprietary market reports, company reports, import/export databases, and secondary data sources on medical device markets were used to develop estimates of the 2019 worldwide market size by product segment, ASPs, sales, and market share for the top suppliers by product segment.
  • Devices in this global market analysis include catheters and guidewires for use in coronary angiography procedures.

Fluorescein Angiography Market Size Worth $617.4 Million By 2027: Grand View Research, Inc.

Retrieved on: 
Wednesday, August 26, 2020
Aromatic compounds, Optical imaging, Medicine, Clinical medicine, Projectional radiography, Fluorescein angiography, Fluorescein, Angiography

However, the growing preference for safer and faster alternatives such as OCT and fundus autofluorescence is anticipated to impede market growth during the forecast period.

Key Points: 
  • However, the growing preference for safer and faster alternatives such as OCT and fundus autofluorescence is anticipated to impede market growth during the forecast period.
  • Despite preference of its alternatives, fluorescein angiography is often used as confirmatory test for a wide range of ophthalmic conditions.
  • In addition, the demand for tradition fluorescein angiography systems is still high in developing countries.
  • Grand View Research has segmented the global fluorescein angiography market based on product, technology, application, and region:

Fluorescein Angiography Market Size Worth $617.4 Million By 2027: Grand View Research, Inc.

Retrieved on: 
Wednesday, August 26, 2020
Aromatic compounds, Optical imaging, Medicine, Clinical medicine, Projectional radiography, Fluorescein angiography, Fluorescein, Angiography

However, the growing preference for safer and faster alternatives such as OCT and fundus autofluorescence is anticipated to impede market growth during the forecast period.

Key Points: 
  • However, the growing preference for safer and faster alternatives such as OCT and fundus autofluorescence is anticipated to impede market growth during the forecast period.
  • Despite preference of its alternatives, fluorescein angiography is often used as confirmatory test for a wide range of ophthalmic conditions.
  • In addition, the demand for tradition fluorescein angiography systems is still high in developing countries.
  • Grand View Research has segmented the global fluorescein angiography market based on product, technology, application, and region: